Osher Town Hall

Professor Eric Nudleman

Age-related macular degeneration (AMD) is the leading cause of vision loss among those aged 50 and older. AMD causes damage to the macula, the central region of the retina necessary for high-acuity vision. In 2010, more than two million Americans had AMD; that number is expected to rise to above five million by 2050. The disease has two forms: wet and dry. Although there are currently no treatments for dry AMD, new therapies for wet AMD have revolutionized the prognosis for patients who previously would have been blind at a much earlier age. This lecture will discuss efforts to improve the delivery of these effective medications and to develop new therapies to further reduce treatment costs and improve the outcomes for patients.